A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants

Clinical trial NCT05412030 · COMPLETED

Trial details

NCT number: NCT05412030
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumonia, Bacterial Pneumococcal Infections Pneumonia, Pneumococcal

Start date: 2022-06-16
Primary completion: 2025-09-18
Enrollment: 388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.